Epidermal growth factor (EGF), which binds to specific highaffinity cell surface receptors, stimulates replication of a number of cell types (1, 2) . In vitro, EGF stimulates a membraneassociated protein kinase that catalyzes phosphorylation at tyrosine residues of a 150,000-170,000 Mr protein thought to be the EGF receptor (3, 4) . EGF-stimulated protein kinase also catalyzes phosphorylation of tyrosine residues in anti-p60s" serum, a substrate for p6Osrc the transforming protein of Rous sarcoma virus (RSV), but, like p60src, does not phosphorylate control serum (5, 6) . This suggests that both EGF-stimulated and p6Osrc tyrosine-specific protein kinases recognize some of the same substrate determinants. Transformation of cells by several retroviruses results in an increase in cellular phosphotyrosine content (7) (8) (9) (10) . Recent studies indicate that EGF also increases cellular phosphotyrosine content in intact human epidermoid carcinoma A431 cells (11, 12) . It has been tempting to speculate that the growth-promoting factor EGF stimulates mitogenesis via changes in covalent modification ofproteins by phosphorylation at tyrosine residues analogous to those induced by the transforming proteins of RNA tumor viruses. However, in contrast to the mitogenic effect of EGF on many cell types, EGF inhibits proliferation of A431 cells (12, 13) . EGF also inhibits growth of rat GH4C1 and certain human breast cancer cells (14, 15) .
To determine whether EGF-stimulated protein kinase activity plays a role in the inhibition of A431 cell growth by EGF, we have isolated variant A431 cells that are resistant to the growth-inhibitory effects of EGF. Six ofthese clones have been analyzed in detail and have been found to contain decreased EGF-stimulated protein kinase activity both in vivo and in vitro.
METHODS Variant Selection and Cell Growth. Parental A431 human epidermoid carcinoma cells were treated with N-methyl-N'-nitro-N-nitrosoguanidine at 1.25 ,g/ml for 2 hr and subsequently grown in Dulbecco's modified Eagle's medium with 10% calf serum containing 0.1 ,M EGF for 3 weeks. This concentration of the mutagen allowed survival of 30% of cells cultured in the absence of EGF. Cells were then subcultured and maintained with 0.1 ,M EGF until visible colonies appeared. From 6 X 107 cells treated with mutagen and continuously maintained with EGF, =300 survived, of which 40 produced large colonies. Six of these colonies were chosen for further study and grown to confluence in the presence of 0.1 AM EGF.
Each clone was then grown for [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and 0.15% Triton X-100 in a final volume of 33 1.d, were incubated for 5 min at 40C. The amount of anti-p60src serum added was saturating for the enzyme present. Reactions were terminated by the addition of EDTA to 30 mM followed immediately by dilution with 150 ,ul ofRIPA buffer (17) , which contains 0. 1% NaDodSO4. Formalin-fixed protein A-containing Staphylococcus aureus (Pansorbin, Calbiochem) was added for 1 hr at 40C to adsorb IgG, and the mixture was centrifuged to separate the immune complex from the EGF receptor-containing supernatant. The supernatant and pellet were individually collected on filter papers by precipitation with trichloroacetic acid (5). After separation on NaDodSO4/10% polyacrylamide gels (18) , phosphorylated proteins were visualized by autoradiography.
Protein concentrations were determined by the fluorescamine assay (19) , using bovine serum albumin in the 0.15% Triton X-100 buffer of the kinase reaction as standard.
RESULTS
Selection of Variant Cells. Because EGF inhibits proliferation ofA431 cells (12) , it appeared possible to select for variants that would grow in the presence of saturating concentrations of EGF. Previous attempts to generate variants of3T3 cells, for which EGF is a mitogen, yielded cells that lacked functional EGF receptors (20) . Because A431 cells have an unusually high density of EGF receptors, 10-to 30-fold greater than most other cells types (21) , a complete loss of EGF receptors was considered unlikely. When exposed to EGF during logarithmic growth, none of the six variants selected for study showed the decreased growth rate characteristic of parental A431 cells (see nref. 12) (Fig. 1) . The ability ofvariant clones to grow in the presence of EGF was maintained when cells were retested after subsequent passages and thus appeared to be a stable change. As shown in Fig. 1C , a slight inhibitory effect of EGF remained in clone 16 -and a slight stimulatory effect was evident in clone 4. Although EGF does not affect logarithmic' growth rates of variant cells, it may still affect an individual variant's morphology, cloning efficiency, or saturation density (unpublished data).
Binding of EGF to Variant Cells. Each of the six variant cell lines had a -reduced number of EGF receptors ( body directed against the EGF receptor, there was reduction of EGF receptors in clone 29 by an, average of 53% compared to parental A431 cells. This compares favorably with the 63% reduction indicated by ligand binding ( Table 1) . Effect of EGF on Cellular Phosphotyrosine Content. In parental A431 cells, EGF increased the cellular content of phosphotyrosine ( Fig. 2 A and B) . This EGF-dependent increase ranged between 5-and 10-fold and resulted in an increase in phosphotyrosine content from 0.02% to 0.22% ofthe acid-stable phosphorylated amino acids in the cell (12) ( Table 2 ). In the EGF-resistant variant cell lines, EGF either failed to detectably increase total cellular phosphotyrosine content (Fig. 2 C and  D) or increased it to a lesser extent (Fig. 2 E and F) . The decrement in EGF stimulation ofcellular phosphotyrosine content of each variant compared to parent A431 cells is summarized in Table 2 . This method of quantitation does not permit detection of increases in phosphotyrosine of less than 2-fold.
EGF-Stimulated Protein Kinase Activity in Solubilized Membranes. Because the sensitivity of detection of reduced levels oftotal cellular phosphotyrosine was limited, a more sensitive in vitro protein kinase assay was used to determine the extent of reduction in EGF-stimulated protein kinase activity in variant cells. Membranes from A431 cells contain an EGFstimulated protein kinase activity that catalyzes phosphorylation at tyrosine residues of a 170,000 Mr protein thought to be the EGF receptor (3) (4) (5) (6) . Because EGF receptors are reduced in variant cells, decreased phosphorylation of putative EGF receptors could reflect either reduced enzyme activity or reduced substrate. Anti-p60'" IgG, an exogenous substrate that is phosphorylated at tyrosine residues by EGF-dependent protein kinase (5, 6), was therefore included, and phosphorylation of both the EGF receptor and added IgG was determined. As shown in Table 3 , EGF-stimulated protein kinase activity was decreased in each ofthe variant cells compared to parental A431 cells. The decrease was apparent when phosphorylation of either the EGF receptor or exogenously added anti-p6Osrc IgG was examined (Table 3 and Fig. 3 ). The extent of reduction of EGF-stimulated protein kinase activity varied among the six resistant lines studied, from =50% of parental levels in clone 16 to =10% ofparental levels in clone 18 . The parallel reduction in phosphorylation of both the EGF receptor and heavy chain of anti-p60src IgG can be used to argue. that kinase activity itself was decreased, not just the availability of the EGF receptor substrate. The decreased phosphotyrosine response of intact cells to EGF was thus confirmed by the reduction in membraneassociated kinase activity.
The reduction in apparent kinase activity did not arise from an altered affinity for ATP (data not shown). There was also no apparent change in the EGF receptor. All variants displayed EGF-stimulated phosphorylation of proteins with the same Mr as in the parental A431 membrane (Fig. 3) . The 170,000 Mr protein, presumed to represent the intact EGF receptor (3, 22) , demonstrated a higher degree ofphosphorylation in the absence of EGF than the 150,000 Mr protein, presumed to represent a proteolytic product of the EGF receptor. Phosphorylation of both was stimulated by EGF. If the data of Tables 1 and 3 are combined, the apparent activity of each variant's EGF-stimulated kinase can be calculated as a function of that variant's remaining EGF receptors (Table  4 ). In the six resistant lines, the decreases in EGF receptors and Autoradiograms as in Fig. 2 were exactly aligned with their counterpart ninhydrin-stained O-phosphorylated amino acid standards on the cellulose plates. Each phosphorylated amino acid was carefully removed and its radioactivity was measured, and phosphotyrosine content was calculated as a percentage of total radioactivity in all three phosphorylated amino acids. The percentage of radioactivity present in phosphoserine and phosphothreonine averaged 94% and 6%, respectively, and did not change with EGF treatment.
EGF-stimulated protein kinase activity were synchronous. Despite reductions in EGF-stimulated kinase activity per mg membrane protein to as low as 10%, variant cells retained the same relative activity per EGF binding site as the parental A431 cells. This was true when either EGF receptor or antip60rc IgG phosphorylation was examined.
DISCUSSION
The isolation of these variant cell lines has opened an avenue for investigation ofthe effects ofEGF on cell proliferation. EGF is presently the only regulator of phosphotyrosine-specific protein kinase activity described. Evidence has been presented that tyrosine-specific protein kinase activities associated with RNA tumor virus transforming proteins mediate transformation (23, 24) and that these viral transforming proteins have homologs in untransformed cells (23, 25) . Whether these viral or cellular tyrosine-specific protein kinases can be regulated or if EGF-stimulated protein kinase is a member of any of these classes is not yet known. Although EGF receptors are clearly involved in the molecular mechanisms through which EGF affects cell proliferation, cell shape, and membrane transport (1), the role of protein phosphorylation in these processes is uncertain. The present studies suggest that EGF-stimulated protein kinase mediates inhibition of proliferation in A431 cells. EGF stimulates an increase in tyrosine-specific protein kinase activity and in cellular phosphotyrosine content in A431 cells in association with growth inhibition. Cells with decreased EGF-stimulated protein kinase activity are no longer growth inhibited by EGF. These data also imply that the EGF-stimulated protein kinase detected in vitro is a primary determinant of the phosphotyrosine content of A431 cells, because, when this kinase activity is decreased, in vivo stimulation of phosphorylation of cellular tyrosine residues by EGF is decreased. Because EGF receptors decreased in parallel with EGF-stimulated protein kinase activity, the possibility that growth inhibition results from an effect ofEGF-receptor occupancy distinct from kinase activation cannot be excluded.
A431 mally quiescent. p65src, the transforming protein of RSV, is derived from a normal cellular protein, p65(-src (26) , and in RSVtransformed cells is present in much greater amounts (-50-fold) than the normal cell protein (27) . It has therefore been proposed that RSV transformation results from a quantitative rather than a qualitative change in a cellular enzyme and its activity (28) . Although EGF causes an increase in cellular phosphotyrosine in A431 cells similar in magnitude to that induced by retroviral transformation in other cells, the EGF-stimulated increases are associated with inhibition of A431 cell growth. Cooper and Hunter have successfully transformed A431 cells with RSV (29) . These cells had a permanently increased phosphotyrosine content from the introduction of the viral protein p60vsrc which produced no significant growth response in the carcinoma-derived A431 cells. However, a further EGF-mediated increase in phosphotyrosine was associated with characteristic growth inhibition (29) .
Cohen et al. (3) have reported that EGF binding and EGFstimulated protein kinase activities are enriched in parallel during purification, suggesting that both activities reside in the same molecule. In addition, EGF-dependent phosphorylation of the EGF receptor has been reported to decrease with receptor down-regulation (30) . Study of A431 variants also provides evidence for the intimate association, perhaps identity,. of the EGF receptor and EGF-stimulated protein kinase. The finding that the specific activity of EGF-stimulated protein kinase per EGF binding site remains constant in six variant cell lines with reductions to as low as 10% in both activities supports the idea that both EGF binding and tyrosine-specific protein kinase activities are located in the same molecule. Alternatively, the kinase may be highly dependent on interaction with the EGF receptor to be active. 
